FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Laboratories Imatinib Mesylate Tablets 100mg Recall

Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90)

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Mar 3, 2021
Recall ID
D-0287-2021
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Imatinib Mesylate Tablets 100mg starting Feb 17, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0287-2021 on Mar 3, 2021. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.

Lot numbers, UPCs & expiration codes

Lot #: a) H2000206, Exp 06/22; b) H2000138, Exp 06/22

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0287-2021
Classification
Class II
Status
Terminated
Recall initiated
Feb 17, 2021
FDA report date
Mar 3, 2021
Quantity
a) 1350 bottles; b) 147 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0287-2021, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
87339
Address
107 College Rd E
Code information
Lot #: a) H2000206, Exp 06/22; b) H2000138, Exp 06/22
Postal code
08540-6623
Report date
Mar 3, 2021
Product type
Drugs
Recall number
D-0287-2021
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
a) 1350 bottles; b) 147 cartons
Termination date
Dec 21, 2022
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 17, 2021
Initial firm notification
Letter
Center classification date
Feb 24, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0287-2021, published Mar 3, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls